Assessment of the Significance of Polymorphic Allelic Variants of the Genes of the Hemostasis System in the Development of Cerebrovascular Disorders in Мetabolic Syndrome

Main Article Content

Shermukhamedova F.K.
Muratov F.Kh.
Asadullaev A.U.
Islamov D.I.


The leading cause of cerebrovascular diseases, including stroke, is the pathology of cerebral vessels.

Article Details

How to Cite
Shermukhamedova F.K., Muratov F.Kh., Asadullaev A.U., & Islamov D.I. (2023). Assessment of the Significance of Polymorphic Allelic Variants of the Genes of the Hemostasis System in the Development of Cerebrovascular Disorders in Мetabolic Syndrome. Journal of Coastal Life Medicine, 11(2), 145–149. Retrieved from


Г.С.Рахимбоева ФК Шермухамедова, Асаб касалликларида пархез овкатланиш // Соглом овкатланиш саломатлик мезони 2015.стр.-241-249

ФХ Муратов, ФК Шермухамедова, БВ Батоцыренов ru Мультимодальное действие цитофлавина при остром мозговом инсульте, развившемся на фоне метаболического синдрома … -

Шермухамедова Ф.К., Муратов Ф.Х., Кирбоев Ж.Т.Ожирение как предиктор острых цереброваскулярных нарушений, Актуальные вопросы медицины и высшего медицинского образования // Бешкек 2022. С.363-372.

M M Asadullaev, F S Saidvaliev, F K Shermukhamedova, Zh K Rizvonov, N M Vakhabova //Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome][Article in Russian]

A Ismatov, F Muratov, F Shermuxamedova Evaluation of the significance of polymorphic allelic genes of the vascular system VEGFΑ in the development of cerebrovascular disorders// - Journal of the Neurological, 2021 - Elsevier

Almawi W.Y., Saldanha F.L., Mahmood N.A., et al. Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage. // Hum Reprod. 2013 Oct;28(10):2628-35. doi: 10.1093/humrep/det308.

Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance // Circulation. –2007 Mar 13. –115(10). –Р.1285-1295.

Friedman J.M. Obesity in the new millennium // Nature.-2000. - Vol. 404. - P.632-634.

Hirashima M. Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling // Anat Sci Int. –2009 Sep. –84(3). –Р.95-101. (doi: 10.1007/s12565-009-0026-1.)

Liu F., Luo L., Wei Y., et al. Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population. // Oncotarget. 2017 Mar 7;8(10):16488-16497. doi: 10.18632/oncotarget.14870.

Li L., Liu H., Xu C., at al. VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43 // Stem Cell Res Ther. –2017 Oct 24. –8(1). –Р.237. (doi 10.1186/s13287-017-0684-1.)

Mackenzie F., Ruhrberg C. Diverse roles for VEGF-A in the nervous system // Development. 2012 Apr; 139(8):1371-80. (doi: 10.1242 / dev. 072348.)

Mattei M.G., Borg J.P., Rosnet O., et al. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively // Genomics. 1996 Feb 15; 32 (1):168-9.

Mizia-Malarz A., Sobol G., Woś H. [Proangiogenic factors: vascular-endothelial growth factor (VEGF) and basic fibroblast growthfactor--the characteristics and function] // Przegl Lek. –2008. –65(7-8). –Р.353-357.

Poredos P., Jezovnik M.K. Testing endothelial function and its clinical relevance // J Atheroscler Thromb. –2013. –20(1).–Р.1-8.

Schaper W. Collateral circulation: past and present // Basic Res Cardiol. 2009 Jan 104(1):5-21. (doi: 10.1007/s00395-008-0760-x. )

Shermukhamedova F. K., Muratov F. Kh. The role of pleiotropic cytokine (TGFΒ) in the devolepment of acute cerebrovascular disorders in the development of acute cerebrovascular disorders in the presence of metabolic syndrome // wos. academiascience/org 2022 Sep/ Issue 9. Volume 3: 93-100.

Shibuya M. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor // FEBS J. –2009 Sep. –276(17). –Р.4636-4643. (doi: 10.1111 / j. 1742-4658. 2009. 07175.x.)

Smith J.R., Lanier V.B., Braziel R.M., et al. Expression of vascular endothelial growth factor and its receptors in rosacea. // Br J Ophthalmol. 2007 Feb; 91(2):226-9.

Shim J.W., Madsen J.R. VEGF Signaling in Neurological Disorders // Int J Mol Sci. 2018 Jan 17; 19(1) pii E275. (doi: 10.3390/ijms19010275.)

Tsiskarishvili T., Katsitadze A., Tsiskarishvili N.I., Chigladze V. [Risk-fsctors of cardiovascular disease in patients with rosacea]. // Georgian Med News. 2017 Jan (262):49-52.

Yamasaki K., Gallo R.L. The molecular pathology of rosacea. // J Dermatol Sci. 2009 Aug; 55 (2):77-81. Doi: 10.1016/j.jdermsci.2009.04.007.

Woo Y.R., Lim J.H., Cho D.H., Park H.J. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous InflammatoryCondition // Int J Mol Sci. 2016 Sep 15; 17(9) pii: E1562. doi: 10.3390/ijms17091562.

Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential // Neurosignals. 2005 14 (5):207-21.